Cargando…

Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II Trial

We investigated the role of the selective avoidance of haematopoietically active pelvic bone marrow (BM), with a targeted intensity-modulated radiotherapy (IMRT) approach, to reduce acute hematologic toxicity (HT) in anal cancer patients undergoing concurrent chemo-radiation. We designed a one-armed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arcadipane, Francesca, Silvetti, Patrick, Olivero, Francesco, Gastino, Alessio, Carlevato, Roberta, Chiovatero, Ilaria, Spinelli, Lavinia, Mistrangelo, Massimiliano, Cassoni, Paola, Ritorto, Giuliana, Gallio, Elena, Lesca, Adriana, Faletti, Riccardo, Giglioli, Francesca Romana, Fiandra, Christian, Ricardi, Umberto, Franco, Pierfrancesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157357/ https://www.ncbi.nlm.nih.gov/pubmed/34069862 http://dx.doi.org/10.3390/jpm11050427

Ejemplares similares

Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial
por: Arcadipane, Francesca, et al.
Publicado: (2020)

Incorporating (18)FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation
por: Franco, Pierfrancesco, et al.
Publicado: (2017)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)
por: Casadei-Gardini, Andrea, et al.
Publicado: (2019)

The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

Radiation therapy for oligometastatic oropharyngeal cancer
por: Martini, Stefania, et al.
Publicado: (2020)

Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations
por: Fiandra, Christian, et al.
Publicado: (2012)

Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer
por: Dapper, Hendrik, et al.
Publicado: (2018)

Value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: an update of the series and a review of the literature
por: Mistrangelo, D M, et al.
Publicado: (2013)

The Prognostic Role of Baseline Eosinophils in HPV-Related Cancers: a Multi-institutional Analysis of Anal SCC and OPC Patients Treated with Radical CT-RT
por: Rimini, Margherita, et al.
Publicado: (2022)

Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
por: Badellino, Serena, et al.
Publicado: (2022)

Long-Term Outcomes of Chemoradiation for Anal Cancer Patients
por: Kim, Hun Jin, et al.
Publicado: (2013)

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
por: Moningi, Shalini, et al.
Publicado: (2019)

IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal
por: Cendales, Ricardo, et al.
Publicado: (2014)

Clinical experience of SIB-IMRT in anal cancer and selective literature review
por: Janssen, Stefan, et al.
Publicado: (2014)

Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches
por: Levis, Mario, et al.
Publicado: (2023)

Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis
por: Koerber, Stefan Alexander, et al.
Publicado: (2014)

Brachytherapy boost after chemoradiation in anal cancer: a systematic review
por: Frakulli, Rezarta, et al.
Publicado: (2018)

IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center
por: Vieillot, Sabine, et al.
Publicado: (2012)

Dose planning objectives in anal canal cancer IMRT: the TROG ANROTAT experience
por: Brown, Elizabeth, et al.
Publicado: (2015)

Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer
por: Innocente, Roberto, et al.
Publicado: (2021)

Penile Mondor's disease in a patient treated with radical chemoradiation for anal cancer
por: Pittaka, Maria, et al.
Publicado: (2017)

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2020)

IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
por: De Felice, Francesca, et al.
Publicado: (2023)

Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT)
por: Durrant, Lisa, et al.
Publicado: (2016)

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions
por: Mantovani, Cristina, et al.
Publicado: (2021)

Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
por: Thind, Govin, et al.
Publicado: (2014)

A multi-disciplinary model of survivorship care following definitive chemoradiation for anal cancer
por: Savoie, Marissa B., et al.
Publicado: (2019)

Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
por: Corrigan, Kelsey L., et al.
Publicado: (2022)

Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
por: Ursino, Stefano, et al.
Publicado: (2022)

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans
por: Menkarios, Cathy, et al.
Publicado: (2007)

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
por: Northover, J, et al.
Publicado: (2010)

Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma
por: Provencher, Sawyna, et al.
Publicado: (2010)

Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
por: Dewas, Claire Vautravers, et al.
Publicado: (2012)

Radiotherapy with Intensity-Modulated (IMRT) Techniques in the Treatment of Anal Carcinoma (RAINSTORM): A Multicenter Study on Behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology) Gastrointestinal Study Group
por: Caravatta, Luciana, et al.
Publicado: (2021)

A Definitive IMRT-SIB with Concomitant Chemotherapy for Synchronous Locally Advanced Anal Canal Cancer and Prostate Cancer
por: Slavisa, Tubin, et al.
Publicado: (2018)

Management of Refractory Metastatic Anal Squamous Cell Carcinoma Following Disease Progression on Traditional Chemoradiation Therapy
por: Silva, Ninoska N., et al.
Publicado: (2012)

Quantification of tumour heterogeneity and glucose metabolism on pre-chemoradiation PET/CT predicts survival in anal cancer
por: Afaq, A, et al.
Publicado: (2015)

Survival prediction models for patients with anal carcinoma receiving definitive chemoradiation: A population-based study
por: Wu, Yinhang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mho7d11cd5avhbl8lmhi0npfm1